Showing results (41-50 of 150) with videos related to
Sort By:
Pageof 15
Journal of Medical Genetics|April 26, 2019
Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)Sabrina Talukdar, Lara Hawkes, Helen Hanson, et al.Journal of Medical Genetics|June 24, 2020
UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variantsHelen Hanson, Angela F Brady, Gillian Crawford, et al.Psycho-Oncology|September 23, 2024
'I Live With Lynch. Cancer Worry Ebbs Into the Background, Then Something Brings It to the Fore.' A Qualitative Interview Study Exploring How Lynch Syndrome Carriers Make Sense of Their Cancer Risks and Implications to Support Decision MakingKelly Kohut, Kate Morton, Lesley Turner, et al.Journal of Medical Genetics|December 5, 2023
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)Kelly Kohut, Beverley Speight, Julie Young, et al.European Journal of Human Genetics : EJHG|August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeFiona Lalloo, Anju Kulkarni, Cindy Chau, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.Journal of Molecular Endocrinology|October 20, 2010
No evidence of RET germline mutations in familial pituitary adenomaElina Heliövaara, Sari Tuupanen, Manuel Ahlsten, et al.Human Mutation|September 4, 2013
UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor geneNaomi C Wake, Christopher J Ricketts, Mark R Morris, et al.Scientific Reports|July 14, 2016
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsAngela George, Daniel Riddell, Sheila Seal, et al.BMC Genomics|March 19, 2005
Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndromeNicholas C M Hearle, Ian Tomlinson, Wendy Lim, et al.Pageof 15